-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, MwGcqshmzKEHlfSalvweF+TSOwF7VarnSyzwz2JkgV0d6pGtCrBGWQfq3hOnL4gE 0gBvi14aCwlBgKXHdVNjIA== 0000950137-07-001310.txt : 20070131 0000950137-07-001310.hdr.sgml : 20070131 20070131171047 ACCESSION NUMBER: 0000950137-07-001310 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20070129 ITEM INFORMATION: Other Events FILED AS OF DATE: 20070131 DATE AS OF CHANGE: 20070131 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SURMODICS INC CENTRAL INDEX KEY: 0000924717 STANDARD INDUSTRIAL CLASSIFICATION: PATENT OWNERS & LESSORS [6794] IRS NUMBER: 411356149 STATE OF INCORPORATION: MN FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-23837 FILM NUMBER: 07568926 BUSINESS ADDRESS: STREET 1: 9924 W 74TH ST CITY: EDEN PRAIRIE STATE: MN ZIP: 55344 BUSINESS PHONE: 6128292700 MAIL ADDRESS: STREET 1: 9924 WEST 74TH ST CITY: EDEN PRAIRIE STATE: MN ZIP: 55344 FORMER COMPANY: FORMER CONFORMED NAME: BSI CORP DATE OF NAME CHANGE: 19970506 8-K 1 c11909e8vk.htm CURRENT REPORT e8vk
Table of Contents

 
 
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): January 29, 2007
SurModics, Inc.
(Exact name of Registrant as Specified in its Charter)
Minnesota
(State or Other Jurisdiction of Incorporation)
     
0-23837
(Commission File Number) 		  41-1356149
(IRS Employer
Identification No.)
9924 West 74th Street
Eden Prairie, Minnesota 55344
(Address of Principal Executive Offices and Zip Code)
(952) 829-2700
(Registrant’s telephone number, including area code)
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
    o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
    o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
    o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
    o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 

 

TABLE OF CONTENTS

Item 8.01 Other Events.
SIGNATURES

Table of Contents

Item 8.01 Other Events.
     On January 29, 2007, the Board of Directors of SurModics, Inc. (the “Company”) approved an amendment to the Company’s previously announced share repurchase program. The previously announced share repurchase program was approved in September 2006 and authorized the Company to repurchase up to $35 million of the Company’s outstanding common stock and up to 1 million shares. In November 2006 pursuant to the previous authorization, the Company entered into a Rule 10b5-1 agreement and purchased $17.5 million of its common stock at an average price of $32.87 per share.
     The amendment to the share repurchase program authorizes the company to repurchase up to $35 million of the Company’s outstanding common stock without restriction as to the total number of shares being repurchased. On January 31, 2007, and pursuant to the amended share repurchase program, the Company entered into a Rule 10b5-1 agreement (the “Agreement”) with a broker to facilitate the repurchase of up to $17.5 million of its outstanding common stock remaining under the $35 million repurchase authorization. Under the Agreement, purchases may be made in open market transactions and shall comply with Rules 10b5-1 and 10b-18 under the Securities Exchange Act of 1934. A Rule 10b5-1 trading plan allows the company to repurchase its common stock in the open market during periods in which stock trading is otherwise closed for the company. All of the repurchased shares will be retired. This 10b5-1 trading plan is expected to extend over the next two to four months.

 

Table of Contents

SIGNATURES
     Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
         
  SURMODICS, INC.
 		  
  By /s/ Philip D. Ankeny    
Date: January 31, 2007  Name:   Philip D. Ankeny   
  Title:   Chief Financial Officer   
 

 

-----END PRIVACY-ENHANCED MESSAGE-----